21.3201
0.2501 (1.19%)
0.2501 (1.19%)
Upgrade to Real-Time
Afterhours (Closed)
Low
7.75
High
29.20
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Humanigen Inc | HGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.2501 | 1.19% | 21.3201 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.54 | 20.90 | 22.37 | 21.11 | 21.07 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 21.32 | 21.51 | 0.19 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,391 | 920,824 | $ 21.53 | $ 19,829,848 | 1,349,160 | 7.75 - 29.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:52 | formt | 351 | $ 21.3201 | USD |
Humanigen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.26B | 59.08M | 37.79M | $ - | $ - | -2.25 | -6.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 404.42k | 1.20% |
Humanigen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.06 | 22.37 | 17.88 | 20.57 | 1,116,716 | 3.26 | 18.05% |
| 1 Month | 18.04 | 23.53 | 17.25 | 19.84 | 1,318,187 | 3.28 | 18.18% |
| 3 Months | 16.33 | 29.20 | 12.3171 | 19.76 | 3,168,189 | 4.99 | 30.56% |
| 6 Months | 9.60 | 29.20 | 9.24 | 19.20 | 2,013,144 | 11.72 | 122.08% |
| 1 Year | 10.85 | 29.20 | 7.75 | 18.11 | 1,600,619 | 10.47 | 96.5% |
| 3 Years | 10.85 | 29.20 | 7.75 | 18.11 | 1,600,619 | 10.47 | 96.5% |
| 5 Years | 10.85 | 29.20 | 7.75 | 18.11 | 1,600,619 | 10.47 | 96.5% |
Humanigen Description
| Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. |
